ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2026
Exit Interviews Examining Patient Experiences with Tirzepatide and Dulaglutide for Treatment of Type 2 Diabetes in the SURPASS-CVOT Trial.
Katie D Stewart et al.PubMed ↗Publisher ↗
No numbers read from the abstract.